To improve your experience on Lilly TrialGuide, please use the latest version of Chrome, Firefox, Safari, or Internet Explorer, with JavaScript enabled.
This website is not optimized for your browser, as configured.
Participation

Lab Samples and Clinical Research: 101

Most of us are pretty familiar with going to the doctor for a routine visit and having blood drawn for lab analysis. Depending on your age and health status, you may also know what it’s like to give samples of urine or even stool, or you may have a health condition that is assessed by giving tissue samples (think of tumor biopsies for certain types of cancer).

Some of these lab samples are easier to give than others, and some are easier to analyze than others. So why are people asked to give lab samples? What kinds of things are learned from assessing lab results?

In clinical research, the number and frequency of lab samples can be much higher than in routine care. This is true for several reasons:

  1. We need to confirm that your health status matches the entry requirements for the research study.
  2. For women who may be able to have children, we check periodically to ensure you have not gotten pregnant during the study. In many cases, we don’t know yet what effect the study medication may have on the baby, and we want to avoid unnecessary risk. So we usually require that both men and women minimize the chance of pregnancy.
  3. We want to be certain the study medication is safe and that you are not experiencing ill effects from taking the study medication.
  4. We need to assess how the study medication is working in your body and compare your results with those of other research participants from all over the world.
  5. In some cases, we want to see if the study medication works better in people with certain types of biomarkers.

The information gathered from the testing of lab samples is some of the most important knowledge we gain in clinical research, so clinical trial participants need to contribute the required lab samples at the time points defined in the study procedures.

The lab data collection process is a key point of discussion in our CoDESIGN sessions. In those sessions, patients and clinical research site staff help ensure we are collecting only the lab samples that are necessary for the research and that we are making it as easy as possible to conduct and participate in the study.

It is also important that research sponsors like Lilly carefully define the lab requirements that answer the research questions. Think about times you have had to give a blood sample, for example. Sometimes the lab technician just needs to fill two vials, but sometimes there is a pile of tubes to fill! For every study we sponsor, we try to avoid the “pile of tubes” scenario to minimize the impact on you. In some cases, lab samples can even be collected at home (for example, a 24-hour urine collection). In these studies, the supplies and instructions would be provided to you.

Now that you know the basics about the role of lab samples in clinical trials, we’re breaking down the key takeaways in the infographic below. Take a look and let us know on Twitter what other research lab-related questions are on your mind.

LabWeek Infographic 17Apr2019-01

Are you or a loved one interested in participating in a clinical trial? Check out Lilly’s enrolling trials here.

Tags: Lab,

Recent Articles

From Alzheimer’s Diagnosis to Advocate

LTGBlogAuthors GuestAuthorIcon 20July2018
Guest Author
January 31st, 20225 minute read

Geri had been involved in research in addition to having a healthcare background. Because of this, after being diagnosed with Alzheimer's she knew that she wanted to participate in a clinical trial.

Committed to Cancer Research

Leigh Anne Naas Headshot
Leigh Anne Naas
September 24th, 20211 minute read

Lilly has a strong legacy in cancer research. Our dedicated oncology team work together to create medicines that make life better for people around the world.

Proud Partners in Breast Cancer Research

Leigh Anne Naas Headshot
Leigh Anne Naas
September 22nd, 20213 minute read

Lilly is proud to foster true partnerships with external stakeholders. By working together to raise awareness of breast cancer research, we can make life better for people around the world.

Recommendations for Decentralized Clinical Trial Capabilities in the Wake of COVID-19

BlogAuthors_Kevin_2Feb2022
Kevin Hudziak
September 15th, 20214 minute read

Tips to implement an effective and successful decentralized clinical trial for multiple touch points.

The COVID-19 Pandemic Changed How Sites Conduct Clinical Trials Forever

BlogAuthors_Kevin_2Feb2022
Kevin Hudziak
July 29th, 20213 minute read

To better understand how various countries adapted to execute clinical trials during a pandemic, we conducted a series of virtual feedback sessions with clinicians from all over the world.

This site is intended for US residents.